Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov platform revision advanced from v3.8.0 to v3.8.1, while the study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-11-21T17:26:21.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A MedlinePlus Genetics link about type 2 diabetes was added among the study’s related health resources.
    Difference
    0.1%
    Check dated 2026-11-14T17:30:19.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The clinical-trial record for DONATE is now displayed, describing a completed observational study of dapagliflozin safety in people with type 2 diabetes in China, along with its eligibility criteria, locations, outcomes, and data-sharing details.
    Difference
    70%
    Check dated 2026-11-07T23:37:59.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T17:34:11.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and a transition from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the page’s 403 error response.
    Difference
    1%
    Check dated 2026-10-24T20:25:28.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:10:27.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.